S&P 500 7,628.29 â–ŧ 57.85 (-0.75%) DOW 52,759.94 â–ŧ 425.96 (-0.80%) NASDAQ 26,096.35 â–ŧ 274.54 (-1.04%) US Markets Closed â€ĸ 05:44 PM ET

OCS

Oculis Holding AG

Price Chart

No historical data available

Latest Quote

$12.13

-0.12 (-0.98%)
Current Price
Previous Close $12.25
Open $12.17
Day High $12.27
Day Low $12.02
Volume 23,746
Fetched: 2026-09-01T16:22:55
Stock Information
Note: Financial values converted from CHF to USD
Shares Outstanding 55.53M
Total Debt $3.13M
Cash Equivalents $281.15M
Revenue $1.44M
Net Income $-97.51M
Sector Healthcare
Industry Biotechnology
Market Cap $673.55M
EPS (TTM) $-1.71
Exchange NGM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Oculis Holding AG

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. Oculis Holding AG was formerly known as Oculis SA and changed its name to Oculis Holding AG in March 2023. The company was founded in 2017 and is based in Zug, Switzerland.

📰 Latest News
No news articles available at the moment. Check back later for updates on OCS.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $0 $0 $0 $0
Operating Revenue $0 $0 $0 $0
Expenses
Interest Expense $1,037,786 $796,093 $1,638,282 $8,025,714
Total Expenses $101,750,408 $91,200,618 $57,123,102 $40,335,381
Other Income Expense $-22,933,460 $-17,768,199 $-53,518,881 $61,046
Net Non Operating Interest Income Expense $1,167,354 $1,904,892 $142,026 $-7,868,738
Interest Expense Non Operating $1,037,786 $796,093 $1,638,282 $8,025,714
Operating Expense $101,750,408 $91,200,618 $57,123,102 $40,335,381
Other Operating Expenses $1,476,323 $2,570,172 $2,263,695 $4,157,375
General And Administrative Expense $28,899,797 $23,572,576 $18,343,778 $8,400,713
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-123,284,787 $-106,864,589 $-110,633,261 $-48,211,594
Net Interest Income $1,167,354 $1,904,892 $142,026 $-7,868,738
Interest Income $2,205,140 $2,700,985 $1,780,308 $156,976
Normalized Income $-100,394,352 $-89,129,472 $-61,663,486 $-48,267,451
Net Income From Continuing And Discontinued Operation $-123,284,787 $-106,864,589 $-110,633,261 $-48,211,594
Total Operating Income As Reported $-101,750,408 $-91,200,618 $-100,556,891 $-40,335,381
Net Income Common Stockholders $-123,284,787 $-106,864,589 $-110,633,261 $-48,211,594
Net Income $-123,284,787 $-106,864,589 $-110,633,261 $-48,211,594
Net Income Including Noncontrolling Interests $-123,284,787 $-106,864,589 $-110,633,261 $-48,211,594
Net Income Continuous Operations $-123,284,787 $-106,864,589 $-110,633,261 $-48,211,594
Pretax Income $-123,516,513 $-107,063,924 $-110,499,956 $-48,143,072
Special Income Charges $0 $0 $-43,433,790 $0
Interest Income Non Operating $2,205,140 $2,700,985 $1,780,308 $156,976
Operating Income $-101,750,408 $-91,200,618 $-57,123,102 $-40,335,381
Depreciation Amortization Depletion Income Statement $255,398 $170,680 $78,488 $89,701
Depreciation And Amortization In Income Statement $255,398 $170,680 $78,488 $89,701
Depreciation Income Statement $255,398 $170,680 $78,488 $89,701
Per Share
Diluted EPS $-2.35 $-2.64 $-3.70 $-14.10
Basic EPS $-2.35 $-2.64 $-3.70 $-14.10
Other
Tax Effect Of Unusual Items $-43,025 $-33,081 $-4,549,105 $5,189
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-98,865,038 $-87,993,820 $-54,985,237 $-39,805,898
Total Unusual Items $-22,933,460 $-17,768,199 $-53,518,881 $61,046
Total Unusual Items Excluding Goodwill $-22,933,460 $-17,768,199 $-53,518,881 $61,046
Reconciled Depreciation $680,230 $505,812 $357,557 $372,507
EBITDA (Bullshit earnings) $-121,798,497 $-105,762,019 $-108,504,117 $-39,744,851
EBIT $-122,478,727 $-106,267,831 $-108,861,674 $-40,117,358
Diluted Average Shares $65,086,648 $50,340,178 $37,250,241 $40,780,611
Basic Average Shares $65,086,648 $50,340,178 $37,250,241 $40,780,611
Diluted NI Availto Com Stockholders $-123,284,787 $-106,864,589 $-110,633,261 $-48,211,594
Tax Provision $-231,727 $-199,335 $133,305 $68,521
Restructuring And Mergern Acquisition $0 $0 $43,433,790 $0
Gain On Sale Of Security $-22,933,460 $-17,768,199 $-10,085,091 $61,046
Research And Development $71,118,891 $64,887,189 $36,437,141 $27,687,593
Selling General And Administration $28,899,797 $23,572,576 $18,343,778 $8,400,713
Other Gand A $10,215,904 $9,275,294 $9,586,754 $2,857,962
Salaries And Wages $18,683,892 $14,297,283 $8,757,023 $5,542,751
Fetched: 2026-08-24
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $227,712,509 $74,863,892 $101,563,532 $-137,288,051
Total Assets $293,972,616 $149,940,822 $142,465,770 $46,170,905
Total Non Current Assets $21,271,506 $19,255,734 $16,617,041 $16,698,020
Other Non Current Assets $977,986 $593,021 $110,880 $92,192
Goodwill And Other Intangible Assets $16,559,732 $16,559,732 $15,206,747 $15,206,747
Other Intangible Assets $16,559,732 $16,559,732 $15,206,747 $15,206,747
Current Assets $272,701,110 $130,685,088 $125,848,730 $29,472,884
Prepaid Assets $5,085,527 $5,880,374 $10,166,071 $3,480,883
Receivables $2,235,041 $1,886,205 $1,499,994 $1,341,772
Other Receivables $1,237,121 $783,635 $1,091,358 $1,136,208
Taxes Receivable $997,919 $1,102,570 $408,636 $205,564
Cash Cash Equivalents And Short Term Investments $265,380,542 $122,918,509 $114,182,665 $24,650,230
Cash And Cash Equivalents $101,323,084 $34,519,790 $47,749,386 $24,650,230
Cash Equivalents - $15,540,633 $27,055,951 -
Cash Financial - $18,979,157 $20,693,436 -
Non Current Deferred Assets - - - $29,900
Non Current Deferred Taxes Assets - - - $29,900
Investmentin Financial Assets - - - $62,292
Debt
Total Debt $2,881,633 $1,470,094 $753,734 $788,618
Long Term Debt And Capital Lease Obligation $2,256,220 $1,077,653 $536,958 $611,708
Current Debt And Capital Lease Obligation $625,413 $392,440 $216,777 $176,910
Net Debt - - - $127,901,877
Long Term Debt - - - $152,552,107
Liabilities
Minimum Pension Liabilities $-2,035,706 $-2,781,965 $-1,335,543 $-328,902
Total Liabilities Net Minority Interest $49,700,375 $58,517,199 $25,695,491 $168,252,208
Total Non Current Liabilities Net Minority Interest $3,919,419 $3,407,378 $1,914,859 $153,277,187
Current Liabilities $45,780,956 $55,109,821 $23,780,632 $14,975,021
Other Current Liabilities $18,037,300 $24,731,210 $6,690,172 $1,246
Payables And Accrued Expenses $21,523,166 $25,381,539 $13,384,081 $8,810,595
Payables $3,407,378 $7,377,876 $9,564,329 $4,817,671
Other Payable $1,164,862 $63,538 $100,913 -
Accounts Payable $2,242,516 $7,314,338 $9,463,416 $4,817,671
Tradeand Other Payables Non Current - $0 $470,928 $0
Other Non Current Liabilities - - - $152,552,107
Non Current Deferred Liabilities - - - $0
Non Current Deferred Taxes Liabilities - - - $0
Equity
Common Stock Equity $244,272,241 $91,423,623 $116,770,279 $-122,081,303
Total Equity Gross Minority Interest $244,272,241 $91,423,623 $116,770,279 $-122,081,303
Stockholders Equity $244,272,241 $91,423,623 $116,770,279 $-122,081,303
Other Equity Interest $37,857,401 $20,010,714 $7,947,226 $3,452,228
Gains Losses Not Affecting Retained Earnings $-2,633,710 $-3,119,588 $-1,742,933 $-702,655
Retained Earnings $-479,043,691 $-355,758,904 $-248,894,315 $-138,261,053
Other
Treasury Shares Number $876,703 $1,245,842 - -
Ordinary Shares Number $72,239,448 $54,396,454 $45,659,742 $40,780,611
Share Issued $73,116,151 $55,642,296 $45,659,742 $40,780,611
Tangible Book Value $227,712,509 $74,863,892 $101,563,532 $-137,288,051
Invested Capital $244,272,241 $91,423,623 $116,770,279 $-122,081,303
Working Capital $226,920,154 $75,575,267 $102,068,098 $14,497,863
Capital Lease Obligations $2,881,633 $1,470,094 $753,734 $788,618
Total Capitalization $244,272,241 $91,423,623 $116,770,279 $-122,081,303
Foreign Currency Translation Adjustments $-598,004 $-337,623 $-407,390 $-373,753
Treasury Stock $8,721 $12,458 $0 $1,246
Additional Paid In Capital $687,369,653 $429,748,215 $359,004,322 $13,382,835
Capital Stock $731,309 $555,646 $455,978 $48,588
Common Stock $731,309 $555,646 $455,978 $48,588
Employee Benefits $1,663,199 $2,329,725 $906,973 $113,372
Non Current Pension And Other Postretirement Benefit Plans $1,663,199 $2,329,725 $906,973 $113,372
Long Term Capital Lease Obligation $2,256,220 $1,077,653 $536,958 $611,708
Current Capital Lease Obligation $625,413 $392,440 $216,777 $176,910
Pensionand Other Post Retirement Benefit Plans Current $5,595,076 $4,604,632 $3,489,603 $5,986,271
Current Accrued Expenses $18,115,789 $18,003,663 $3,819,752 $3,992,924
Net PPE $3,733,788 $2,102,981 $1,299,413 $1,399,081
Accumulated Depreciation $-1,120,012 $-1,007,886 $-842,189 $-686,459
Gross PPE $4,853,800 $3,110,867 $2,141,602 $2,085,540
Leases $221,760 $122,093 $0 -
Other Properties $3,941,844 $2,405,721 $1,710,541 $1,691,853
Machinery Furniture Equipment $690,196 $583,054 $431,061 $393,686
Properties $0 $0 $0 -
Other Short Term Investments $164,057,458 $88,398,719 $66,433,279 $0
Investments And Advances - - - $62,292
Duefrom Related Parties Current - - - -
Fetched: 2026-08-24
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-84,333,537 $-61,231,888 $-68,627,207 $-35,658,490
Operating Activities
Operating Cash Flow $-82,604,308 $-60,945,345 $-68,567,406 $-31,238,242
Cash Flow From Continuing Operating Activities $-82,604,308 $-60,945,345 $-68,567,406 $-31,238,242
Operating Gains Losses $15,442,212 $19,304,322 $4,061,445 $-11,213
Investing Activities
Capital Expenditure $-1,729,229 $-286,544 $-59,800 $-4,420,247
Investing Cash Flow $-75,914,136 $-20,036,877 $-65,995,988 $-4,420,247
Cash Flow From Continuing Investing Activities $-75,914,136 $-20,036,877 $-65,995,988 $-4,420,247
Financing Activities
Issuance Of Capital Stock $222,830,054 $66,703,627 $168,954,863 $2,529,059
Financing Cash Flow $232,870,295 $67,245,568 $161,493,515 $2,135,373
Cash Flow From Continuing Financing Activities $232,870,295 $67,245,568 $161,493,515 $2,135,373
Net Other Financing Charges $-16,472,523 $-3,605,467 $-9,455,941 $-345,098
Cash Dividends Paid $0 $0 $0 -
Net Common Stock Issuance $222,830,054 $66,703,627 $168,954,863 $0
Common Stock Issuance $222,830,054 $66,703,627 $168,954,863 $0
Net Preferred Stock Issuance - $0 $0 $2,529,059
Preferred Stock Issuance - $0 $0 $2,529,059
Other
Repayment Of Debt $-464,699 $-341,361 $-196,843 $-198,089
End Cash Position $101,323,084 $34,519,790 $47,749,386 $24,650,230
Beginning Cash Position $34,519,790 $47,749,386 $24,650,230 $57,653,830
Effect Of Exchange Rate Changes $-7,548,557 $507,058 $-3,830,964 $520,762
Changes In Cash $74,351,851 $-13,736,654 $26,930,121 $-33,524,362
Interest Paid Cff $-108,388 $-67,275 $-57,309 -
Proceeds From Stock Option Exercised $27,085,851 $4,556,044 $2,248,745 $149,501
Net Issuance Payments Of Debt $-464,699 $-341,361 $-196,843 $-198,089
Net Long Term Debt Issuance $-464,699 $-341,361 $-196,843 $-198,089
Long Term Debt Payments $-464,699 $-341,361 $-196,843 $-198,089
Interest Received Cfi $1,546,090 $1,836,371 $1,542,352 -
Net Investment Purchase And Sale $-75,730,998 $-21,586,704 $-67,478,540 $0
Purchase Of Investment $-75,730,998 $-21,586,704 $-67,478,540 $0
Net Intangibles Purchase And Sale $-1,354,230 $0 $0 $-4,339,268
Purchase Of Intangibles $-1,354,230 $0 $0 $-4,339,268
Net PPE Purchase And Sale $-374,998 $-286,544 $-59,800 $-80,980
Purchase Of PPE $-374,998 $-286,544 $-59,800 $-80,980
Taxes Refund Paid $-68,521 $-189,368 $-125,830 $-24,917
Change In Working Capital $-92,192 $17,642,369 $-16,184,733 $7,472,560
Change In Other Working Capital $-139,534 $-118,355 $-36,129 -
Change In Other Current Assets $2,926,483 $6,205,539 $-6,921,898 $-2,237,532
Change In Payables And Accrued Expense $-2,425,654 $11,247,462 $-9,271,556 $9,899,461
Change In Payable $-2,425,654 $11,247,462 $-9,271,556 $3,791,097
Change In Account Payable $-2,425,654 $11,718,390 $-9,742,484 $3,791,097
Change In Receivables $-453,486 $307,723 $44,850 $-189,368
Other Non Cash Items $4,962,189 $-3,331,382 $49,329,114 $8,061,844
Stock Based Compensation $19,988,289 $12,186,826 $4,494,998 $1,001,657
Depreciation Amortization Depletion $680,230 $505,812 $357,557 $372,507
Depreciation And Amortization $680,230 $505,812 $357,557 $372,507
Depreciation $680,230 $505,812 $357,557 $372,507
Pension And Employee Benefit Expense $125,830 $-44,850 $-213,039 $-11,213
Gain Loss On Investment Securities $15,316,382 $19,349,172 $4,274,484 -
Net Income From Continuing Operations $-123,516,513 $-107,063,924 $-110,499,956 $-48,143,072
Interest Received Cfo - $1,836,371 $1,542,352 $156,976
Interest Paid Cfo - $-67,275 $-57,309 $-124,584
Change In Accrued Expense - $13,846,288 $-14,388,229 $6,108,363
Net Foreign Currency Exchange Gain Loss - - $-37,375 $726,326
Change In Prepaid Assets - - - -
Fetched: 2026-08-24